ReleaseWire Connect

The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth”. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market forecasts up to 2019. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV therapeutics R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global HIV therapeutics market. The report analyzes the market for HIV therapeutics in eight major markets of the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), Japan and Canada.

Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free Survival and Targeted Therapies”. The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carboplatin and paclitaxel, which are used in combination for the treatment of platinum-sensitive disease (both first-line and recurrent).

Research’s report: “Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets” discusses the market, competitive landscape, and trends for two facial aesthetics market segments: Botox and dermal fillers. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important merger and acquisition deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Market Snapshot: Glucose Monitoring Devices 2006 to 2020 Benelux and Scandinavia (Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway)” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in 2013 for the following countries: are Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Research, the leading business intelligence provider, has released its latest research: ‘Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 – Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries ’, which provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top five European countries (the UK, France, Germany, Spain and Italy), Japan and Canada.

Research, the leading business intelligence provider, has released its latest research: ‘Breast Cancer Therapeutics in Major Developed Markets to 2020 – Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs ’, which provides in-depth analysis of breast cancer therapeutics market within the eight major geographies of the US, Canada, the top five geographies in Europe (the UK, France, Germany, Spain and Italy) and Japan.

Research’s report: “Transcatheter Heart Valves 2007 to 2020 – Americas” provides quantitative analysis of the transcatheter heart valves market in Americas. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for the following countries: US, Canada, Brazil and Mexico. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, Germany, Italy, Spain, Japan and Canada.

Mobile Value Added Services (VAS) applications are provided within telecommunications as a means of creating customer “stickiness” while adding top line revenue and improved margins. The mobile VAS marketplace is dynamic, driven by handset OEMs, network operators, content owners, and MVAS innovators such as OnMobile. Originally incubated by Infosys, the company offers a wide range of products and services, which are evaluated in this report. Already a market leader in India, the company is poised to gain market share in other areas.

3D printing is currently the subject of a great deal of speculation and excitement in the media. Touted as the technology to bring about the next industrial revolution and the in-sourcing of manufacturing jobs back to the West, the term in fact refers to a raft of technologies each of which is compatible for use with a particular material type.